Cancer cells hijack a fatty acid to escape immune attack in liver metastases
Collaboration aims to develop new class of medicines for in vivo CAR-T
Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples
White paper looks at early clinical development of B-cell depletion therapies in autoimmune disease
Aukera Therapeutics emerges from stealth
FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial
Platform to test new cancer treatments
Potential biomarker for targeted psoriasis therapy discovered
Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin
Sobi boosts gout battle with Arthrosi Therapeutics acquisition
Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints